|
⚲
|
| Keyboard |
| Chee Conley
✚
|
|
|---|---|
| CIK # | 0001883804 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001883804] | |
| 4 | [0001883804] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Chee Conley | |
| Syros Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-11-18 | Sell | 134,797 | $0.20 | 26,959 |
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2024-10-31 | Option exercise | 17,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-10-31 | Option exercise | 17,000 | ||
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-10-31 | Tax withheld | 8,707 | $2.09 | 18,198 |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-09-11 | Buy | 50,000 | $1.71 | 85,500 |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-09-10 | Buy | 50,000 | $1.51 | 75,500 |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-04-01 | Tax withheld | 3,500 | $5.12 | 17,920 |
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2024-03-31 | Option exercise | 11,666 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2024-03-31 | Option exercise | 2,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-03-31 | Option exercise | 2,000 | ||
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2024-03-31 | Option exercise | 11,666 | ||
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2023-12-02 | Grant | 86,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2023-11-01 | Tax withheld | 6,004 | $2.22 | 13,329 |
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2023-10-31 | Option exercise | 17,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2023-10-31 | Option exercise | 17,000 | ||
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2023-04-03 | Tax withheld | 658 | $2.58 | 1,698 |
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2023-03-31 | Option exercise | 2,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Common Stock
|
2023-03-31 | Option exercise | 2,000 | ||
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2023-02-16 | Grant | 35,000 | $0.00 | |
|
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
|
2022-10-06 | Grant | 34,000 | $0.00 | |
| showing 20 of 24 most recent transactions | |||||